1. Home
  2. WTRG vs CYTK Comparison

WTRG vs CYTK Comparison

Compare WTRG & CYTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Essential Utilities Inc.

WTRG

Essential Utilities Inc.

HOLD

Current Price

$40.92

Market Cap

11.4B

Sector

Utilities

ML Signal

HOLD

Logo Cytokinetics Incorporated

CYTK

Cytokinetics Incorporated

HOLD

Current Price

$79.38

Market Cap

10.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTRG
CYTK
Founded
1901
1997
Country
United States
United States
Employees
1615
N/A
Industry
Water Supply
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
11.4B
10.7B
IPO Year
1994
2004

Fundamental Metrics

Financial Performance
Metric
WTRG
CYTK
Price
$40.92
$79.38
Analyst Decision
Hold
Strong Buy
Analyst Count
5
19
Target Price
$43.50
$89.26
AVG Volume (30 Days)
1.9M
1.8M
Earning Date
05-07-2026
05-05-2026
Dividend Yield
3.47%
N/A
EPS Growth
1.38
N/A
EPS
1.16
N/A
Revenue
$2,474,615,000.00
$13,368,000.00
Revenue This Year
$5.07
$7.37
Revenue Next Year
$7.31
$310.19
P/E Ratio
$35.14
N/A
Revenue Growth
18.62
N/A
52 Week Low
$36.11
$35.22
52 Week High
$42.37
$88.31

Technical Indicators

Market Signals
Indicator
WTRG
CYTK
Relative Strength Index (RSI) 57.90 48.55
Support Level $37.88 $73.34
Resistance Level $41.61 $79.66
Average True Range (ATR) 0.78 2.31
MACD 0.04 0.19
Stochastic Oscillator 82.86 55.81

Price Performance

Historical Comparison
WTRG
CYTK

About WTRG Essential Utilities Inc.

Essential Utilities is a Pennsylvania-based holding company for US water, wastewater, and natural gas distribution utilities. The company's water business serves 3 million people in eight states. Its largest service territory is in Pennsylvania, primarily suburban Philadelphia. Its Peoples subsidiary serves more than 740,000 gas distribution customers in Pennsylvania and Kentucky. It completed the sale of its West Virginia gas utility and the bulk of its nonregulated assets in 2024. Essential shareholders would own a 31% stake in American Water Works if the proposed all-stock merger closes in 2027.

About CYTK Cytokinetics Incorporated

Cytokinetics Inc is a late-stage biopharmaceutical company focused on discovering, developing, and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The company's product, named as MYQORZO, is an allosteric and reversible inhibitor of cardiac myosin motor activity. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Share on Social Networks: